←Back to Expert Scholars
Translational Medicine / 转化医学HER2 NSCLC, EGFR Resistance
Zofia Piotrowska
MD, MHS
🏢Massachusetts General Hospital🌐USA
Associate Professor of Medicine
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Zofia Piotrowska focuses on targeted therapy for oncogene driven NSCLC including HER2 mutant disease. She contributes to trials of HER2 TKIs and ADCs and studies resistance mechanisms to these agents. Her translational work connects clinical outcomes with tumor biology.
Share:
🧪Research Fields 研究领域
HER2 mutant NSCLC
EGFR resistance
clinical trials
targeted therapy
thoracic oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Zofia Piotrowska 的研究动态
Follow Zofia Piotrowska's research updates
留下邮箱，当我们发布与 Zofia Piotrowska（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment